EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment

Hannah Egan, Oliver Treacy, Kevin Lynch, Niamh A Leonard, Grace O'Malley, Eileen Reidy, Aoise O'Neill, Shania M Corry, Kim De Veirman, Karin Vanderkerken, Laurence J Egan, Thomas Ritter und 13 weitere

Cell Reports · 2023-05 · 42 (5) · 112475

DOI: 10.1016/j.celrep.2023.112475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023-05. Verfasst von Hannah Egan und 24 weiteren Autor:innen. Beteiligte Einrichtung: Discipline of Pharmacology and Therapeutics, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Irel…. Hauptthemen laut MEDLINE: Neoplasms, Cancer-Associated Fibroblasts. Die Arbeit wurde bisher 103-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, European Commission, College of Medicine, Nursing and Health Sciences, National University of Ireland, Galway.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunosuppressive tumor microenvironments (TMEs) reduce the effectiveness of immune responses in cancer. Mesenchymal stromal cells (MSCs), precursors to cancer-associated fibroblasts (CAFs), promote tumor progression by enhancing immune cell suppression in colorectal cancer (CRC). Hyper-sialylation of glycans promotes immune evasion in cancer through binding of sialic acids to their receptors, Siglecs, expressed on immune cells, which results in inhibition of effector functions. The role of sialylation in shaping MSC/CAF immunosuppression in the TME is not well characterized. In this study, we show that tumor-conditioned stromal cells have increased sialyltransferase expression, α2,3/6-linked sialic acid, and Siglec ligands. Tumor-conditioned stromal cells and CAFs induce exhausted immunomodulatory CD8+ PD1+ and CD8+ Siglec-7+/Siglec-9+ T cell phenotypes. In vivo, targeting stromal cell sialylation reverses stromal cell-mediated immunosuppression, as shown by infiltration of CD25 and granzyme B-expressing CD8+ T cells in the tumor and draining lymph node. Targeting stromal cell sialylation may overcome immunosuppression in the CRC TME.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCancer-Associated FibroblastsHumansCD8-Positive T-LymphocytesTumor MicroenvironmentImmunosuppression TherapyStromal CellsSialic Acid Binding Immunoglobulin-like Lectins

Stichwörter der Autor:innen

CP: CancerCP: ImmunologyT cell exhaustionT cellscancer-associated fibroblastscolon cancerimmunotherapyinflammationsialylationsiglecsstromal cellstumor microenvironment

Substanzen

Sialic Acid Binding Immunoglobulin-like Lectins

Autor:innen und Institutionen

  • Discipline of Pharmacology and Therapeutics, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland; Regenerative Medicine Institute (REMEDI), School of Medicine, Col…
  • Patrick G Johnston Centre for Cancer Research, Queen's University Belfast, Belfast, UK.
  • Laboratory for Haematology and Immunology (HEIM), Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium.
  • Discipline of Pharmacology and Therapeutics, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland; Lambe Institute for Translational Research, School of Medicine, C…
  • Regenerative Medicine Institute (REMEDI), School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland; CÚRAM, SFI Research Centre for Medical Devices, University of Galway…
  • Lambe Institute for Translational Research, School of Medicine, College of Medicine, Nursing and Health Sciences, University of Galway, Galway, Ireland; Department of Colorectal Surgery, Galway University Hospital, Galw…

Förderung

  • Cancer Research UK
  • European Commission
  • College of Medicine, Nursing and Health Sciences, National University of Ireland, Galway
  • Science Foundation Ireland
  • University of Galway
  • Fonds Wetenschappelijk Onderzoek
  • European Regional Development Fund
  • Health Research Board

Zitieren

APA

Egan, H., Treacy, O., Lynch, K., Leonard, N. A., O'Malley, G., Reidy, E., O'Neill, A., Corry, S. M., De Veirman, K., Vanderkerken, K., Egan, L. J., Ritter, T., Hogan, A. M., Redmond, K., Peng, L., Che, J., Gatlin, W., Jayaraman, P., Sheehan, M., …, & Ryan, A. E. (2023). Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment. Cell Reports, 42(5), 112475. https://doi.org/10.1016/j.celrep.2023.112475

Vancouver

Egan H, Treacy O, Lynch K, Leonard NA, O'Malley G, Reidy E, et al. Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment. Cell Reports. 2023;42(5):112475. doi:10.1016/j.celrep.2023.112475

BibTeX
@article{Egan2023,
  author = {Egan, Hannah and Treacy, Oliver and Lynch, Kevin and Leonard, Niamh A and O'Malley, Grace and Reidy, Eileen and O'Neill, Aoise and Corry, Shania M and De Veirman, Kim and Vanderkerken, Karin and Egan, Laurence J and Ritter, Thomas and Hogan, Aisling M and Redmond, Keara and Peng, Li and Che, Jenny and Gatlin, Wayne and Jayaraman, Pushpa and Sheehan, Margaret and Canney, Aoife and Hynes, Sean O and Kerr, Emma M and Dunne, Philip D and O'Dwyer, Michael E and Ryan, Aideen E},
  title = {Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment},
  journal = {Cell Reports},
  year = {2023},
  volume = {42},
  number = {5},
  pages = {112475},
  doi = {10.1016/j.celrep.2023.112475}
}
Kostenlos starten →